no code implementations • 17 Oct 2023 • Priyanka Vasanthakumari, Thomas Brettin, Yitan Zhu, Hyunseung Yoo, Maulik Shukla, Alexander Partin, Fangfang Xia, Oleksandr Narykov, Rick L. Stevens
Several error analysis metrics such as the false positive rate (FPR), and the prediction uncertainty are evaluated, and the results are summarized by cancer type and drug mechanism of action (MoA) category.
no code implementations • 18 Nov 2022 • Alexander Partin, Thomas S. Brettin, Yitan Zhu, Oleksandr Narykov, Austin Clyde, Jamie Overbeek, Rick L. Stevens
A wave of recent papers demonstrates promising results in predicting cancer response to drug treatments while utilizing deep learning methods.